The European Society of Cardiology (ESC) 2023 congress featured results from a wide range of thought-provoking clinical trials. Dr Sarah Birkhoelzer and Dr Aaron Henry run through ten of the most noteworthy, including STEP-HFpEF, NOAH AFNET and HEART-FID.

Professor Terry McCormack and Dr Devin Gray recap some of the new evidence presented at the European Society of Cardiology (ESC) 2023 congress with the greatest impact on primary care: a head-to-head comparison of statins, bempedoic acid for reducing LDL cholesterol, and managing the ongoing cardiovascular risks in patients living with, or who have recovered from, cancer.